Related Experiment Video
Updated: Feb 16, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Recurrent hypoglycaemia in a toddler on β-blocker therapy
Véronique Pépin1, Nancy Gagné1, Diane Rottembourg1
1Department of Pediatrics,Centre Hospitalier Universitaire de Sherbrooke,Sherbrooke,Quebec,Canada.
Insights
Propranolol can cause severe hypoglycemia in children, even without prolonged fasting or significant ketosis. Beta-blocker therapy may disrupt normal glucose metabolism and worsen ketotic hypoglycemia.
Area of Science:
- Pediatric Endocrinology
- Clinical Pharmacology
- Metabolic Disorders
Background:
- Hypoglycemia is a recognized adverse effect of propranolol, a beta-blocker medication.
- Beta-blockers are commonly prescribed for various pediatric conditions, including cardiovascular and neurological disorders.
Abstract:
Hypoglycaemia is a well-known side effect of Propranolol. We described the case of a child presenting severe and recurrent Propranolol-induced hypoglycaemia. Those episodes were not related to prolonged fasting and were associated with only mild ketosis. Thus, therapy with β blockers may not only aggravate classical ketotic hypoglycaemia but also interfere with glucose metabolism.
Related Concept Videos
Hypoglycemia and Glucagon
Depolarizing Blockers: Pharmocokinetics
Gene Therapy
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Group Therapy
Drugs Acting on Autonomic Ganglia: Blockers

